Acid challenge to the esophageal mucosa: effects on local nitric oxide formation and its relation to epithelial functions
- PMID: 15844695
- DOI: 10.1007/s10620-005-2550-8
Acid challenge to the esophageal mucosa: effects on local nitric oxide formation and its relation to epithelial functions
Abstract
To evaluate the effect of esophageal acid exposure on epithelial function, transmucosal potential, histopathological markers of acute tissue damage, and local nitric oxide production were examined in healthy volunteers treated with proton pump inhibitors (group I), patients with treated reflux disease (group II), and patients with untreated erosive reflux disease (group III). The participants were randomized to esophageal perfusion with either saline or HCl. Denominators of acute acid exposure were balloon cells in superficial layers and superficial densification. The nitric oxide concentrations in groups I to III increased from < 1, 10.0+/-10.0, and 20.6+/-19.9 ppb, respectively, to 300+/-80, 1360+/-1080, and 920+/-700 ppb after HCl infusion (P < 0.001). Inducible nitric oxide synthase was consistently expressed in the epithelium. Blood flow was lower among reflux patients but did not correlate with acid exposure or nitric oxide. Nitric oxide is formed following acid perfusion and predominantly in gastroesophageal reflux disease.
Similar articles
-
Acid challenge to the human esophageal mucosa: effects on epithelial architecture in health and disease.Dig Dis Sci. 2005 Aug;50(8):1488-96. doi: 10.1007/s10620-005-2867-3. Dig Dis Sci. 2005. PMID: 16110841 Clinical Trial.
-
Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.J Gastroenterol Hepatol. 2008 Feb;23(2):303-9. doi: 10.1111/j.1440-1746.2007.05113.x. Epub 2007 Aug 27. J Gastroenterol Hepatol. 2008. PMID: 17725600 Clinical Trial.
-
Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.J Physiol Pharmacol. 2014 Dec;65(6):809-22. J Physiol Pharmacol. 2014. PMID: 25554985
-
Pathophysiology of gastro-esophageal reflux disease: a role for mucosa integrity?Neurogastroenterol Motil. 2013 Oct;25(10):783-99. doi: 10.1111/nmo.12201. Epub 2013 Aug 12. Neurogastroenterol Motil. 2013. PMID: 23937353 Review.
-
Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease.Am J Gastroenterol. 2008 Apr;103(4):1021-8. doi: 10.1111/j.1572-0241.2007.01688.x. Epub 2007 Dec 12. Am J Gastroenterol. 2008. PMID: 18076734 Review.
Cited by
-
In Vitro Modelling of Barrier Impairment Associated with Gastro-Oesophageal Reflux Disease (GERD).Clin Exp Gastroenterol. 2021 Sep 8;14:361-373. doi: 10.2147/CEG.S325346. eCollection 2021. Clin Exp Gastroenterol. 2021. PMID: 34526798 Free PMC article.
-
Updates on the Role of Periodontitis-Related Epigenetics, Inflammation, Oral Microbiome, and Treatment in Cardiovascular Risk.J Inflamm Res. 2024 Feb 7;17:837-851. doi: 10.2147/JIR.S449661. eCollection 2024. J Inflamm Res. 2024. PMID: 38344306 Free PMC article. Review.
-
Expression of inducible nitric oxide synthase, nitrotyrosine, eosinophilic peroxidase, eotaxin-3, and galectin-3 in patients with gastroesophageal reflux disease, eosinophilic esophagitis, and in healthy controls: a semiquantitative image analysis of 3,3'-diaminobenzidine-stained esophageal biopsies.Dis Esophagus. 2024 Aug 29;37(9):doae034. doi: 10.1093/dote/doae034. Dis Esophagus. 2024. PMID: 38679488 Free PMC article.
-
Acid challenge to the human esophageal mucosa: effects on epithelial architecture in health and disease.Dig Dis Sci. 2005 Aug;50(8):1488-96. doi: 10.1007/s10620-005-2867-3. Dig Dis Sci. 2005. PMID: 16110841 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical